Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma

Kathryn McCauley1, Juliana Durack1, Ricardo Valladares1

  • 1Department of Medicine, University of California, San Francisco, Calif.

Insights

Distinct nasal bacteria in children with asthma impact respiratory illness severity and exacerbation risk. Specific bacterial communities, like Moraxella, are linked to higher exacerbation risk, while others may offer protection.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatric Respiratory Medicine

Background:

  • Infant nasopharyngeal bacterial communities are linked to respiratory infections and asthma development.
  • The role of nasal microbiota in children with asthma requires further investigation.

Purpose of the Study:

  • To investigate the association between distinct nasal airway microbiota structures in children with asthma and clinical outcomes.
  • To determine if nasal microbiota composition relates to asthma exacerbations, rhinovirus infections, and respiratory illnesses.

Main Methods:

  • 16S rRNA profiling of nasal secretion samples from 413 children with asthma (aged 6-17 years).
  • Statistical analysis correlating microbiota composition with exacerbations, rhinovirus infections, and respiratory illnesses.
  • In vitro assessment of bacterial isolates (Moraxella, Staphylococcus, Corynebacterium) for epithelial damage and inflammatory responses.

Main Results:

  • Six distinct nasal microbiota assemblages were identified, dominated by Moraxella, Staphylococcus, Corynebacterium, Streptococcus, Alloiococcus, or Haemophilus.
  • Moraxella-dominated microbiotas were associated with increased exacerbation risk and eosinophil activation.
  • Staphylococcus or Corynebacterium-dominated microbiotas correlated with reduced respiratory illness and exacerbations, while Streptococcus-dominated ones increased rhinovirus infection risk.
  • Moraxella catarrhalis induced greater epithelial damage and inflammatory responses in vitro compared to other tested isolates.

Conclusions:

  • Distinct nasal airway microbiotas in children with asthma are associated with the likelihood of exacerbations, rhinovirus infections, and respiratory illnesses.
  • Nasal microbiota composition shows relative stability despite infections or exacerbations, with minor fluctuations in dominant taxa.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K